Results 221 to 230 of about 30,174 (282)

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

American Journal of Hematology, Volume 101, Issue 7, Page 1597-1604, July 2026.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo, Elisa Sambruna, Yoshitaka Miyakawa, Marc Michel, Carlo Visco, Michael Fillitz, George Kannourakis, Maria Bruna Greve, Moritz Kleemiss, Johan Cid, Andrea Patriarca, Laura Pavan, Arbana Dizdari, Nilla Maschio, Antonella Sau, Cinzia Bitetti, Riccardo Mario Colombo, Luigi Curreli, Dorela Lame, Uros Markovic, Fabrizio Pappagallo, Giacinto Luca Pedone, Davide Rapezzi, Vincenzo Sammartano, Nicola Tumedei, Antonio Giovanni Solimando, Jalink Marit, Luana Fianchi, Jahanzaib Khwaja, Antonio De Vivo, Francesco Lanza, Fabrizio Vianello, Esther N. Oliva, Catherine Broome, Francesco Passamonti, Ulrich Jaeger, Bernd Jilma, Guillaume Moulis, Wilma Barcellini   +38 more
wiley   +1 more source

Paternal perinatal mental health and early child development: An outcome‐wide analysis

Infant Mental Health Journal: Infancy and Early Childhood, Volume 47, Issue 4, July 2026.
Abstract Paternal mental health (PMH) has been shown to associate with child development as early as infancy. However, the moderating effects of certain contextual factors remain poorly understood. Using data from the French SEPAGES cohort, an outcome‐wide analytic approach was used to investigate the relationship between PMH during pregnancy (n = 166),
Honor Scarlett, Xavier Benarous, Angèle Consoli, Tina Montreuil, Sarah Lyon‐Caen, Claire Philippat, Judith van der Waerden   +6 more
wiley   +1 more source

CAR‐T Cells in Ulcerative Colitis: The Renaissance of B‐Cell Targeted Therapy in UC

JCC Plus, Volume 1, Issue 4, July 2026.
ABSTRACT A recent New England Journal of Medicine report described the first successful use of anti‐CD19 CAR‐T cell therapy in a patient with multirefractory ulcerative colitis (UC). This exceptional case provides striking proof of concept that B cells and plasma cells can act as key pathogenic drivers in UC.
Zlata Chkolnaia, Mathieu Uzzan, Walter Reinisch   +2 more
wiley   +1 more source

Beyond Parity: Gender Inequities and Recommendations in Infectious Diseases and Clinical Microbiology Research. [PDF]

Infect Dis Clin Microbiol
Çevik M, Last K, Papan C, Huttner A, Delliere S.   +4 more
europepmc   +1 more source

Social network characteristics and levels of fluctuations in momentary depressive symptomatology among older adults. [PDF]

J Epidemiol Community Health
Cail V, Beenackers MA, Van Lenthe FJ, Oude Groeniger J, Fancello G, Montanari A, Sueur C, Kestens Y, Vallée J, Chaix B.   +9 more
europepmc   +1 more source

Land Under Siege: Militarized Capitalism and Urban Land Dispossession in the City of Goma, Eastern Democratic Republic of Congo

Antipode, Volume 58, Issue 4, July 2026.
ABSTRACT This article investigates the relationship between militarization and land grabbing in the context of rapid urbanization and protracted violent conflict in the Democratic Republic of Congo. Drawing on two case studies of the dispossession and privatization of public urban land in Goma, Eastern Congo, during the state of siege, the paper ...
Benjamin Muhoza, Karen Büscher, Sam Kniknie   +2 more
wiley   +1 more source

Clinical outcomes of carbapenem therapy in OXA-48-producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis. [PDF]

Emerg Microbes Infect
Dortet L, Moreau C, Dinh A, Bonnin RA, Escaut L, Seguret M, Weber L, Figueiredo S, Pilmis B.   +8 more
europepmc   +1 more source

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6142-6150, July 2026.
ABSTRACT Aims The fibrosis‐4 (FIB‐4) score is used to identify risk of advanced liver fibrosis. This post hoc analysis investigated its prognostic value for cardiovascular (CV) outcomes and its relevance to the effects of dapagliflozin. Materials and Methods DECLARE‐TIMI 58 was a randomised, placebo‐controlled phase 3 trial investigating dapagliflozin ...
Jan Oscarsson, Monika Huhn, Yunyun Jiang, Ingrid Gause‐Nilsson, Stephen D. Wiviott, Filipe A. Moura, John P. H. Wilding, Simona Cernea, Luc Van Gaal, Avivit Cahn, Deepak L. Bhatt, Peter A. Johansson, C. David Sjöström   +12 more
wiley   +1 more source

Responding to the toxic drug crisis: Promising innovations, gaps, and calls to action. [PDF]

Can J Public Health
Urbanoski K, Moore D, Neudorf C, Hyshka E, Knight R.   +4 more
europepmc   +1 more source